换一批
换一批Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study.
作者：
Andrew N,Phillips [1]
;
Anna,Bershteyn [2]
;
Paul,Revill [3]
;
Loveleen,Bansi-Matharu [4]
;
Katharine,Kripke [5]
;
Marie-Claude,Boily [6]
;
Rowan,Martin-Hughes [7]
;
Leigh F,Johnson [8]
;
Zindoga,Mukandavire [9]
;
Lise,Jamieson [10]
;
Gesine,Meyer-Rath [11]
;
Timothy B,Hallett [6]
;
Debra,Ten Brink [7]
;
Sherrie L,Kelly [7]
;
Brooke E,Nichols [12]
;
Eran,Bendavid [13]
;
Edinah,Mudimu [14]
;
Isaac,Taramusi [15]
;
Jennifer,Smith [4]
;
Shona,Dalal [16]
;
Rachel,Baggaley [16]
;
Siobhan,Crowley [17]
;
Fern,Terris-Prestholt [18]
;
Peter,Godfrey-Faussett [19]
;
Irene,Mukui [20]
;
Andreas,Jahn [21]
;
Kelsey K,Case [22]
;
Diane,Havlir [23]
;
Maya,Petersen [24]
;
Moses,Kamya [25]
;
Catherine A,Koss [23]
;
Laura B,Balzer [26]
;
Tsitsi,Apollo [27]
;
Thato,Chidarikire [28]
;
John W,Mellors [29]
;
Urvi M,Parikh [29]
;
Catherine,Godfrey [30]
;
Valentina,Cambiano [4]
;
HIV Modelling Consortium
作者单位：
Institute for Global Health, University College London, London, UK. Electronic address: andrew.phillips@ucl.ac.uk.
[1]
Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
[2]
Centre for Health Economics, University of York, York, UK.
[3]
Institute for Global Health, University College London, London, UK.
[4]
Avenir Health, Takoma Park, MD, USA.
[5]
Department of Infectious Disease Epidemiology, Imperial College London, London, UK; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
[6]
Burnet Institute, Melbourne, VIC, Australia.
[7]
Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.
[8]
Centre for Data Science and Artificial Intelligence, Emirates Aviation University, Dubai, United Arab Emirates.
[9]
Health Economics and Epidemiology Research Office (HE2RO), Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Medical Microbiology, Amsterdam University Medical Centre, Amsterdam, Netherlands.
[10]
Health Economics and Epidemiology Research Office (HE2RO), Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Global Health, School of Public Health, Boston University, Boston, MA, USA.
[11]
Health Economics and Epidemiology Research Office (HE2RO), Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Medical Microbiology, Amsterdam University Medical Centre, Amsterdam, Netherlands; Department of Global Health, School of Public Health, Boston University, Boston, MA, USA.
[12]
Department of Medicine, Stanford University, Stanford, CA, USA.
[13]
Department of Decision Sciences, University of South Africa, Pretoria, South Africa.
[14]
National AIDS Council, Harare, Zimbabwe.
[15]
World Health Organisation, Geneva, Switzerland.
[16]
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland.
[17]
Joint UN Programme on HIV/AIDS, Geneva, Switzerland.
[18]
Joint UN Programme on HIV/AIDS, Geneva, Switzerland; London School of Hygiene & Tropical Medicine, London, UK.
[19]
Drugs for Neglected Diseases Initiative, Nairobi, Kenya.
[20]
Ministry of Health, Lilongwe, Malawi.
[21]
Department of Infectious Disease Epidemiology, Imperial College London, London, UK.
[22]
Department of Medicine, University of California, San Francisco, CA, USA.
[23]
Divisions of Biostatistics and Epidemiology, School of Public Health, University of California, Berkeley, CA, USA.
[24]
Department of Medicine, Makerere University, Kampala, Uganda; Infectious Diseases Research Collaboration, Kampala, Uganda.
[25]
Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA, USA.
[26]
Ministry of Health and Child Care, Harare, Zimbabwe.
[27]
National Department of Health, Pretoria, South Africa.
[28]
Department of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA, USA.
[29]
Office of the Global AIDS Coordinator, Department of State, Washington, DC, USA.
[30]
主题词
成年人(Adult);抗HIV药(Anti-HIV Agents);费用效益分析(Cost-Benefit Analysis);疾病流行(Epidemics);女(雌)性(Female);HIV感染(HIV Infections);人类(Humans);男(雄)性(Male)
DOI
10.1016/S2352-3018(22)00029-7
PMID
35489378
发布时间
2024-12-07
- 浏览2
The lancet. HIV
The lancet. HIV
2022年9卷5期
e353-e362页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
